164 related articles for article (PubMed ID: 19790154)
1. Mesenchymal stem cells as immunomodulators after liver transplantation.
Popp FC; Renner P; Eggenhofer E; Slowik P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
Liver Transpl; 2009 Oct; 15(10):1192-8. PubMed ID: 19790154
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by mesenchymal stem cells and clinical experience.
Le Blanc K; Ringdén O
J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
[TBL] [Abstract][Full Text] [Related]
3. Modulation of immune responses by mesenchymal stem cells.
Fibbe WE; Nauta AJ; Roelofs H
Ann N Y Acad Sci; 2007 Jun; 1106():272-8. PubMed ID: 17442776
[TBL] [Abstract][Full Text] [Related]
4. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase.
Meisel R; Brockers S; Heseler K; Degistirici O; Bülle H; Woite C; Stuhlsatz S; Schwippert W; Jäger M; Sorg R; Henschler R; Seissler J; Dilloo D; Däubener W
Leukemia; 2011 Apr; 25(4):648-54. PubMed ID: 21242993
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells.
Bernardo ME; Locatelli F; Fibbe WE
Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
[TBL] [Abstract][Full Text] [Related]
6. An in vitro assay to evaluate the immunomodulatory effects of unrestricted somatic stem cells.
Ebrahimi H; Soleimani M; Kazemi Arababadi M; Ahmadbeigi N; Hassanshahi G; Farjadfar A; Kennedy D
Iran J Immunol; 2010 Mar; 7(1):30-8. PubMed ID: 20371917
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived mesenchymal stem cells as immunosuppressants in liver transplantation: a review of current data.
Zhang H; Chen Z; Bie P
Transfus Med Rev; 2012 Apr; 26(2):129-41. PubMed ID: 22015073
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells can affect solid organ allograft survival.
Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
11. Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.
Leal A; Ichim TE; Marleau AM; Lara F; Kaushal S; Riordan NH
Cell Immunol; 2008; 253(1-2):11-5. PubMed ID: 18627903
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells might be used to induce tolerance in heart transplantation.
Zhou H; Jin Z; Liu J; Yu S; Cui Q; Yi D
Med Hypotheses; 2008; 70(4):785-7. PubMed ID: 17959317
[TBL] [Abstract][Full Text] [Related]
13. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients.
Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Alwayn IP; Weimar W; Hoogduijn MJ
Transplantation; 2009 Mar; 87(6):896-906. PubMed ID: 19300194
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.
Opitz CA; Litzenburger UM; Lutz C; Lanz TV; Tritschler I; Köppel A; Tolosa E; Hoberg M; Anderl J; Aicher WK; Weller M; Wick W; Platten M
Stem Cells; 2009 Apr; 27(4):909-19. PubMed ID: 19353519
[TBL] [Abstract][Full Text] [Related]
15. Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation.
Crop M; Baan C; Weimar W; Hoogduijn M
Transpl Int; 2009 Apr; 22(4):365-76. PubMed ID: 19000235
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation.
Kuo YR; Chen CC; Goto S; Lin PY; Wei FC; Chen CL
Clin Dev Immunol; 2012; 2012():854846. PubMed ID: 23227090
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.
Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y
Nat Rev Nephrol; 2018 Aug; 14(8):493-507. PubMed ID: 29895977
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive function of bone marrow mesenchymal stem cells on acute rejection of liver allografts in rats.
Hong ZF; Huang XJ; Yin ZY; Zhao WX; Wang XM
Transplant Proc; 2009; 41(1):403-9. PubMed ID: 19249567
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells and inflammatory lung diseases.
Iyer SS; Co C; Rojas M
Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
[TBL] [Abstract][Full Text] [Related]
20. The role of indoleamine 2,3 dioxygenase in the induction of immune tolerance in organ transplantation.
Palafox D; Llorente L; Alberú J; Torres-Machorro A; Camorlinga N; Rodríguez C; Granados J
Transplant Rev (Orlando); 2010 Jul; 24(3):160-5. PubMed ID: 20541386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
